Submit Deal

CORMORANT ASSET MANAGEMENT

HQ - Boston

Summary

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

Deals Overview

Total Deals51

Valued Deals50

Total Value£ 6.89 B

Avg. Deal Size£ 138 M

Market Context

Subsidiaries

HELIX ACQUISITION

1 transaction

Senior Management

Bihua Chen
CEO
Caleb Tripp
CFO
Raymond Kelleher
Managing Director

Sort

27 Apr 2020|United States|Biotechnology

Target: ERASCA

Bidder: ARCH VENTURE PARTNERS

10 Service Providers

3 Target | 7 Bidder

22 Dealmakers

8 Target | 14 Bidder

£ 161 M

Value

20 May 2020|United States|Pharmaceuticals

Target: ATEA PHARMACEUTICALS INC

Bidder: ALLY BRIDGE GROUP

15 Service Providers

2 Target | 13 Bidder

27 Dealmakers

4 Target | 24 Bidder

£ 175 M

Value

05 Jun 2020|China|Pharmaceuticals

Target: EVEREST MEDICINES LTD

Bidder: OCTAGON INVESTMENTS

11 Service Providers

3 Target | 8 Bidder

18 Dealmakers

7 Target | 12 Bidder

£ 245 M

Value

16 Jun 2020|United States|Biotechnology

Target: GREENLIGHT BIOSCIENCES INC

Bidder: MLS CAPITAL FUND II

11 Service Providers

1 Target | 10 Bidder

12 Dealmakers

1 Target | 11 Bidder

£ 81 M

Value

04 Sep 2020|China|Pharmaceuticals

Target: I-MAB

Bidder: HILLHOUSE CAPITAL GROUP

18 Service Providers

6 Target | 12 Bidder

33 Dealmakers

8 Target | 25 Bidder

£ 315 M

Value

08 Jul 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: CORMORANT ASSET MANAGEMENT

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 105 M

Value

03 Mar 2020|United States|Medical Equipment

Target: ELEMENT SCIENCE INC

Bidder: THE INVUS GROUP LLC

10 Service Providers

3 Target | 7 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 114 M

Value

17 Jul 2020|United States|Pharmaceuticals

Target: BIOATLA

Bidder: SOLEUS CAPITAL

10 Service Providers

2 Target | 8 Bidder

14 Dealmakers

6 Target | 8 Bidder

£ 55 M

Value

15 Oct 2020|Switzerland|Biotechnology

Target: VECTIVBIO

Bidder: CORMORANT ASSET MANAGEMENT

16 Service Providers

3 Target | 13 Bidder

35 Dealmakers

16 Target | 21 Bidder

£ 84 M

Value

28 Oct 2020|United States|Biotechnology

Target: MIRAGEN THERAPEUTICS

Bidder: VENROCK

16 Service Providers

5 Target | 11 Bidder

19 Dealmakers

5 Target | 14 Bidder

£ 70 M

Value

16 Dec 2020|United States|Biotechnology

Target: NEUROGENE INC

Bidder: CASDIN CAPITAL

13 Service Providers

2 Target | 11 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 85 M

Value

11 Jan 2021|China|Pharmaceuticals

Target: VISEN PHARMACEUTICALS

Bidder: ORBIMED PE

12 Service Providers

1 Target | 11 Bidder

13 Dealmakers

1 Target | 12 Bidder

£ 111 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy